ML18302A100

Public Meeting (Webinar) to Accept Comments on the Nrc'S Evaluation of Training and Experience Requirements for Different Categories of Radiopharmaceuticals (83 Fr 54380)

ML18302A100
Person / Time
Issue date:	10/29/2018
From:	Office of Nuclear Material Safety and Safeguards
To:
References
PMNS20181146
Download: ML18302A100 (2)

Text

Title:

Public Meeting (WEBINAR) to Accept Comments on the NRC's Evaluation of Training and Experience Requirements for Different Categories of Radiopharmaceuticals (83 FR 54380)

Date(s) and Time(s): November 14, 2018, 01:00 PM to 03:00 PM Location: Webinar Category: This is a Category 3 meeting. Public participation is actively sought for this meeting to fully engage the public in a discussion of regulatory issues.

Purpose:

To solicit comments from the public and stakeholders on the NRC's evaluation of the training and experience (T&E) requirements for a physician to become an authorized user for medical uses under Subpart E, Unsealed Byproduct MaterialWritten Directive Required, of Title 10 of the Code of Federal Regulations (10 CFR) Part 35, Medical Use of Byproduct Material. Notice soliciting comments was published in the Federal Register on October 29, 2018 (83 FR 54380).

Contact:

Sarah Lopas 301-415-6360 Sarah.Lopas@nrc.gov

Participants:

NRC Office of Nuclear Material Safety and Safeguards Bridge Number Pass Code Teleconference:

(888) 452-5182 3340287 URL Meeting Number Password Webinar:

https://attendee.gotowebinar. Webinar ID: 219-367-715 Not applicable.

com/register/3944692972591850755 Comments: Federal Register notice (83 FR 54380) can be accessed at https://www.gpo.gov/fdsys/pkg/FR-2018-10-29/pdf/2018-23521.pdf.

Additional meetings on this topic will be held on December 11, 2018 (in-person meeting at NRC Headquarters and webinar); January 10, 2019 (in-person meeting at NRC Headquarters and webinar); and January 22, 2019 (webinar-only).

PUBLIC MEETING AGENDA

Public Meeting (WEBINAR) to Accept Comments on the NRC's Evaluation of Training and Experience Requirements for Different Categories of Radiopharmaceuticals (83 FR 54380)

November 14, 2018, 01:00 PM to 03:00 PM Webinar

The time of the meeting is local to the jurisdiction where the meeting is being held.

The NRC provides reasonable accommodation to individuals with disabilities where appropriate. If reasonable accommodation is needed to participate in this meeting, or if a meeting notice, transcript, or other information from this meeting is needed in another format (e.g., Braille, large print), please notify the NRC meeting contact.

Determinations on requests for reasonable accommodation will be made on a case-by-case basis.

ADAMS Accession Number: ML18302A100 Distribution:

OFFICIAL RECORD COPY Link to meeting details: https://www.nrc.gov/pmns/mtg?do=details&Code=20181146 Commission's Policy Statement on "Enhancing Public Participation in NRC Meetings" 67 Federal Register 36920, May 28, 2002 The policy statement may be found on the NRC website http://www.nrc.gov/reading-rm/doc-collections/commission/policy/67fr36920.html